Atalanta Therapeutics
Biotechnology Research • 
Boston, Massachusetts, United States • 51-100 Employees
Company overview
| Headquarters | 51 Sleeper Street, Boston, MA 02210, US |
| Phone number | +13393308780 |
| Website | |
| NAICS | 541714 |
| Employees | 51-100 |
| Socials |
Key Contacts at Atalanta Therapeutics
Joanne Dove Kotz
Ceo
Bruno Mdc Godinho
Associate Director
Maurine Braun
Director, Nonclinical Development
Antonio Narciso
Sr. Director Information Technology
Corrie Gallant-Behm
Sr. Director, Research
Megan Leader
Sr. Director, Clinical Development Operations
Tim Umland
Associate Director, Cmc Project Management
Matthew Hassler
Associate Director
Eleni Tsiroyannis
Associate Director Clinical Operations
Scott Johnson
Director
Atalanta Therapeutics Email Formats
Atalanta Therapeutics uses 5 email formats. The most common is {first initial}{last name} (e.g., jdoe@atalantatx.com), used 74.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@atalantatx.com | 74.1% |
{first name}{last name} | johndoe@atalantatx.com | 19% |
{last name}{last name} | doedoe@atalantatx.com | 3.4% |
{first initial} | j@atalantatx.com | 1.7% |
{last name}{first initial} | doej@atalantatx.com | 1.7% |
About Atalanta Therapeutics
Atalanta Therapeutics is a biotechnology company developing treatments for intractable diseases of the central nervous system using RNA interference. Atalanta’s unique platform of divalent small interfering RNA (di-siRNA) enables durable, selective gene silencing throughout the brain and spinal cord. Atalanta is advancing a wholly owned pipeline of disease-modifying programs for Huntington’s disease, genetic epilepsy, severe chronic pain, and other neurological diseases in addition to partnered programs as part of a strategic collaboration with Genentech. We were founded by Anastasia Khvorova, Ph.D., Craig Mello, Ph.D., and Neil Aronin, M.D. of the RNA Therapeutics Institute at the University of Massachusetts Medical School. Atalanta is headquartered in Boston, Mass.
Atalanta Therapeutics revenue & valuation
| Annual revenue | $14,300,000 |
| Revenue per employee | $247,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $45,800,000 |
| Total funding | $207,000,000 |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Atalanta Therapeutics has 23 employees across 12 departments.
Departments
Number of employees
Funding Data
Explore Atalanta Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Atalanta Therapeutics Tech Stack
Discover the technologies and tools that power Atalanta Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Miscellaneous
Analytics
JavaScript libraries
CDN
Analytics
Font scripts
JavaScript libraries
JavaScript libraries
Webmail
Miscellaneous
United Arab Emirates
Czechia
Germany
Frequently asked questions
4.8
40,000 users
